Abstract
The potential of genetically fusing recombinant proteins to the simian immunodeficiency virus (SIV) Tat protein has been investigated. The recombinant SIV Tat protein was initially expressed in very low amounts in E. coli, but optimization of the coding sequence for translation in the bacterial host significantly improved protein expression. Whilst fusion of SIV Tat to an experimental antigen (GST) facilitated the binding of the antigen to cell surfaces it did not appear to facilitate the transport of the protein into the cytosol. The immunogenicity of GST was significantly enhanced, in the absence of adjuvants, when fused to SIV Tat, with the induction of IgG1 and IgG2a antibodies indicative of a Th 1 response being induced. However, no evidence was obtained that such an immunization scheme efficiently induced a CTL response. (c) 2005 Elsevier Ltd. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 708-715 |
| Number of pages | 8 |
| Journal | Vaccine |
| Volume | 24 |
| DOIs | |
| Publication status | Published - 6 Feb 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- SIV Tat fusion proteins
- Th1/Th2
- IgG2a
- adjuvant
- immunogenicity
- HUMAN-IMMUNODEFICIENCY-VIRUS
- MHC CLASS-I
- T-CELL
- TRANSDUCTION DOMAIN
- ESCHERICHIA-COLI
- SOLUBLE-PROTEIN
- DELIVERY
- VACCINE
- RESPONSES
- ANTIGEN
Fingerprint
Dive into the research topics of 'Genetic fusion of proteins to the SIV Tat protein enhances their immunogenicity.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver